Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Presenter: James Udelson

February 12, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

Innovation in Heart Failure Trial Designs

Presenter: Ori Ben-Yehuda

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Advertisement

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

This Strategy Has Saved the Startup Medical Device Sector

Down-Stream Challenges: Reimbursement and Guidelines

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

BrioHealth Solutions: Pump and Clinical Trial Design

The Promise of AI for Improving Health Equity in Heart Failure

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Innovation in Heart Failure Trial Designs

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content